Get your prescription with FREE Instant video consultation
Get it in 3 hours
{{badgeTamara}} Split in {{numberOfInstallments}} interest-free payments of {{repaymentAmount}}
Trusted & Free Shipping
100% Secure Payment
Genuine Brands
Overview
Dispensing Mode: Prescription only medication
Active Ingredient: Semaglutide 0.25 mg (GLP-1 receptor agonist injectable)
Primary Use: Initial dose for chronic weight management in adults with obesity or overweight when combined with diet and increased physical activity
Benefits
Used in the initiation of chronic weight management to support gradual weight loss when paired with a reduced-calorie diet and increased physical activity
Helps regulate appetite and reduce hunger by mimicking the GLP-1 hormone pathway that promotes fullness
Facilitates smoother dose escalation with an introductory dose designed to improve tolerability before moving to higher weekly doses
How to Use
Disclaimer: This product is a prescription-only medicine and must be used strictly under the supervision of a licensed healthcare professional. Always adhere to the directions provided on the prescription label. Consult your doctor if you have any questions or concerns regarding its use.
Description
Wegovy 0.25 mg FlexTouch Pre-Filled Pen is a prescription injectable medication containing semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist developed for long-term chronic weight management in adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with at least one weight-related comorbidity (such as type 2 diabetes, high blood pressure, or high cholesterol). This 0.25 mg dose is typically the starter dose used during the first few weeks of treatment to help the body adapt to therapy before escalating to higher therapeutic doses that deliver more pronounced weight-lowering effects. The medication is administered once weekly by subcutaneous injection using the easy-to-use FlexTouch pen, and the included needles are used for safe, accurate self-injection into the abdomen, thigh, or upper arm. Proper training by a healthcare provider on injection technique and dose escalation is recommended before beginning treatment. Regular clinical follow-up and monitoring help ensure the medicine is effective and well-tolerated.